Ascendis Pharma A/S ASND:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:32 PM EDT
141.21quote price arrow up+5.31 (+3.91%)
Volume
120,748
52 week range
76.02 - 161.00
Loading...
  • Open136.48
  • Day High142.43
  • Day Low136.48
  • Prev Close135.90
  • 52 Week High161.00
  • 52 Week High Date02/26/24
  • 52 Week Low76.02
  • 52 Week Low Date05/01/23

Key Stats

  • Market Cap8.149B
  • Shares Out57.71M
  • 10 Day Average Volume0.29M
  • Dividend-
  • Dividend Yield-
  • Beta0.53
  • YTD % Change11.78

KEY STATS

  • Open136.48
  • Day High142.43
  • Day Low136.48
  • Prev Close135.90
  • 52 Week High161.00
  • 52 Week High Date02/26/24
  • 52 Week Low76.02
  • 52 Week Low Date05/01/23
  • Market Cap8.149B
  • Shares Out57.71M
  • 10 Day Average Volume0.29M
  • Dividend-
  • Dividend Yield-
  • Beta0.53
  • YTD % Change11.78

RATIOS/PROFITABILITY

  • EPS (TTM)-9.44
  • P/E (TTM)-14.95
  • Fwd P/E (NTM)-31.60
  • EBITDA (TTM)-466.844M
  • ROE (TTM)-818.43%
  • Revenue (TTM)285.174M
  • Gross Margin (TTM)83.36%
  • Net Margin (TTM)-180.51%
  • Debt To Equity (MRQ)-442.20%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ascendis Pharma A/S

 

Profile

MORE
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma...
Albert Cha M.D., Ph.D.
Independent Chairman of the Board
Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
Scott Smith
Chief Financial Officer, Executive Vice President, Member of the Executive Board
Peter Rasmussen
Principal Accounting Officer, Vice President - Finance
Camilla Hartvig
Executive Vice President, Global Chief Commercial Officer
Address
Tuborg Boulevard 12
Hellerup
2900
Denmark

Top Peers

SYMBOLLASTCHG%CHG
ROIV
Roivant Sciences Ltd
11.16+0.13+1.22%
ITCI
Intra-Cellular Therapies Inc
72.96-0.30-0.41%
CERE
Cerevel Therapeutics Holdings Inc
42.70+0.23+0.55%
CYTK
Cytokinetics Inc
63.11-2.23-3.41%
VKTX
Viking Therapeutics Inc
74.55+0.24+0.32%